Get the Stockscreener App
8.13
0.73%
-0.06
Anteris Technologies Global Corp stock is traded at $8.13, with a volume of 501.72K.
It is down -0.73% in the last 24 hours and down -21.83% over the past month.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
See More
Previous Close:
$8.19
Open:
$8.32
24h Volume:
501.72K
Relative Volume:
0.42
Market Cap:
$791.39M
Revenue:
$1.85M
Net Income/Loss:
$-95.19M
P/E Ratio:
-3.6608
EPS:
-2.2208
Net Cash Flow:
$-86.88M
1W Performance:
-3.79%
1M Performance:
-21.83%
6M Performance:
+25.85%
1Y Performance:
+147.87%
1-Day Range:
$8.05
$8.39
1-Week Range:
$7.97
$8.63
52-Week Range:
$2.9901
$11.05
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
8.13 | 791.39M | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-11-26 | Initiated | Wells Fargo | Overweight |
| Jan-08-25 | Initiated | Lake Street | Buy |
| Jan-07-25 | Initiated | Barclays | Overweight |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-07-25 | Initiated | TD Cowen | Buy |
View All
Anteris Technologies Global Corp Stock (AVR) Latest News
AVR|Anteris Technologies Global Corp|Price:8.125|Chg%:-0.065 - TradingKey
AVR|Anteris Technologies Global Corp|Price:8.113|Chg%:-0.077 - TradingKey
Anteris Technologies Files Appendix 3G for New Share Issue - TipRanks
Anteris Technologies Executes 500 Unquoted Options at US$5.71 Strike, Issuing Common Shares - Kalkine Media
Anteris Technologies (AVR) AGM 2025 Summary - Quartr
One Anteris Technologies Global Insider Raised Their Stake In The Previous Year - simplywall.st
AVR Forecast — Price Target — Prediction for 2027 - TradingView
Anteris Technologies Seeks ASX Quotation for New AVR Securities - TipRanks
Anteris Technologies Global Corp. Announces Issuance of Unquoted Employee Incentive Securities - Kalkine Media
Anteris Technologies Issues New Unquoted Equity Under Employee Incentive Plan - TipRanks
Anteris Technologies Global Corp. Issues New Unquoted Securities as Part of Employee Incentive Scheme - Kalkine
Anteris Technologies (AVR) Option Scheme Meeting Summary - Quartr
Anteris Technologies (AVR) Drops 6.15% as Stock Tests Key Support at $9.42Trend Reversal Picks - dars.gov.et
Anteris Announces Results for the First Quart - Moomoo
Anteris Technologies (AVR) Posts 2.15% Gain as Stock Tests Key Resistance LevelDealer Gamma - dars.gov.et
ChartWatch ASX Scans: CSL, Cochlear, Artrya, Anteris Technologies, AMP, Zip Co, Graincorp, Pexa - Market Index
Anteris Technologies files form S-3 to register 5.39M shares via warrants - MSN
AVR Q1 2026 Earnings: EPS Misses Estimates as Clinical Advances Continue; Shares Up 3%Earnings Acceleration Picks - dars.gov.et
Anteris Technologies Sees 51,701 Net CDI Decrease in June 2026 as Investors Shift Holdings to Nasdaq Shares - Kalkine Media
Could Anteris Technologies Global Corp (ASX:AVR) Continue Its Momentum After 162% One-Year Rally? - Kalkine
Anteris Technologies Reports Net CDI Reduction of 51,701 as Holders Shift to Nasdaq Common Stock in June 2026 - Kalkine
Anteris adjusts CDI and common stock balances amid ASX–Nasdaq transfers - TipRanks
Anteris Files Shelf Registration to Support Advanced Heart Valve Portfolio - TipRanks
Anteris Technologies Files Offering of Up to 5.39 Million Shares - Moomoo
AVR Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Company Advances Clinical PipelineProfit Announcement - dars.gov.et
Anteris Technologies Reports Lapse of Restricted Stock Units and Options - TipRanks
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 2000 Value Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Price to earnings forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to earnings forward of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies Global Corp. Actuals & Estimates (NASDAQ:AVR) - TradingView
ChartWatch ASX Scans: Ramsay Health Care, Woolworths, Aristocrat Leisure, Sunrise Energy Metals, Anteris Technologies - Market Index
Price to book forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to sales forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Enterprise value to revenue forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Issues 45,631 New Shares from Conversion of Unquoted Securities - TipRanks
Anteris adds 23,072 new CDIs to ASX listing - TipRanks
Anteris Technologies Global Corp (AVR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AVR Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesEPS Growth Report - dars.gov.et
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Anteris director David Roberts converts RSUs into common stock under long-term incentive plan - TipRanks
Anteris Technologies (AVR) Proxy filing Summary - Quartr
Anteris Technologies Global Corp (AVR) Institutional Confidence - TradingKey
Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anteris Technologies Global Corp Stock (AVR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Knight Susan Elizabeth | Director |
Jun 02 '26 |
Buy |
9.29 |
11,000 |
102,228 |
11,000 |
| L1 Capital Pty Ltd | 10% Owner |
Jan 22 '26 |
Buy |
5.75 |
5,000,000 |
28,750,000 |
13,219,814 |
3.37%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):